How I prescribe prolonged intermittent renal replacement therapy

被引:6
|
作者
Clark, Edward G. [1 ]
Vijayan, Anitha [2 ]
机构
[1] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada
[2] Washington Univ, Div Nephrol, St Louis, MO USA
关键词
CRITICALLY-ILL PATIENTS; INTENSITY; DIALYSIS; FAILURE;
D O I
10.1186/s13054-023-04389-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Prolonged Intermittent Renal Replacement Therapy (PIRRT) is the term used to define 'hybrid' forms of renal replacement therapy. PIRRT can be provided using an intermittent hemodialysis machine or a continuous renal replacement therapy (CRRT) machine. Treatments are provided for a longer duration than typical intermittent hemodialysis treatments (6-12 h vs. 3-4 h, respectively) but not 24 h per day as is done for continuous renal replacement therapy (CRRT). Usually, PIRRT treatments are provided 4 to 7 times per week. PIRRT is a cost-effective and flexible modality with which to safely provide RRT for critically ill patients. We present a brief review on the use of PIRRT in the ICU with a focus on how we prescribe it in that setting.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] A therapeutic regimen of ceftazidime-avibactam for a critical patient receiving prolonged intermittent renal replacement therapy
    Yan, Yu-ying
    Jin, Yi
    Cao, Xiang-yuan
    Chen, Song-yu
    Liu, Wen-hao
    Shen, Chen-Rui
    Qiu, Yu-shuang
    Shen, Fu-ming
    Ni, Min
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (06) : 620 - 623
  • [32] Renal replacement therapy modalities in the ICU: the continuity is intermittent
    Schefold, Joerg C.
    INTENSIVE CARE MEDICINE, 2016, 42 (11) : 1838 - 1839
  • [33] Renal replacement therapy modalities in the ICU: the continuity is intermittent
    Joerg C. Schefold
    Intensive Care Medicine, 2016, 42 : 1838 - 1839
  • [34] Renal replacement therapy in acute kidney injury: Intermittent versus continuous? How much is enough?
    Bouchard, Josee
    Weidemann, Charlotte
    Mehta, Ravindra L.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2008, 15 (03) : 235 - 247
  • [35] Fosfomycin single- and multiple-dose pharmacokinetics in patients undergoing prolonged intermittent renal replacement therapy
    Gerecke, Lisa K., V
    Schmidt, Julius J.
    Hafer, Carsten
    Eden, Gabriele
    Bode-Boeger, Stefanie M.
    Martens-Lobenhoffer, Jens
    Welte, Tobias
    Kielstein, Jan T.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (01) : 169 - 173
  • [36] Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermittent renal replacement therapy: A systematic review
    Grewal, Arvind
    Thabet, Pierre
    Dubinsky, Samuel
    Purkayastha, Debanjali
    Wong, Kristy
    Marko, Ryan
    Hiremath, Swapnil
    Hutton, Brian
    Kanji, Salmaan
    PHARMACOTHERAPY, 2023, 43 (11): : 1206 - 1220
  • [37] Comparison of continuous and intermittent renal replacement therapy for acute renal failure
    Uehlinger, DE
    Jakob, SM
    Ferrari, P
    Eichelberger, M
    Huynh-Do, U
    Marti, HP
    Mohaupt, MG
    Vogt, B
    Rothen, HU
    Regli, B
    Takala, J
    Frey, FJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (08) : 1630 - 1637
  • [38] Renal replacement therapy in the treatment of acute renal failure - Intermittent and continuous
    John, Stefan
    Eckardt, Kai-Uwe
    SEMINARS IN DIALYSIS, 2006, 19 (06) : 455 - 464
  • [39] IMPACT OF PROLONGED CONTINUOUS RENAL REPLACEMENT THERAPY ON MORTALITY AND RENAL RECOVERY
    Ostapenko, Alexander
    Li, Ya-Huei
    Lissauer, Mathew
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [40] Renal replacement therapy in the ICU: intermittent hemodialysis, sustained low-efficiency dialysis or continuous renal replacement therapy?
    Wang, Amanda Ying
    Bellomo, Rinaldo
    CURRENT OPINION IN CRITICAL CARE, 2018, 24 (06) : 437 - 442